Drug Discovery

Day One Bio commits to creating purposeful treatments for children with life-threatening diseases

Thermo Fisher Scientific and UCSF launch new cell therapy manufacturing site to accelerate advanced cell therapies development

The Lung Cancer Research Foundation has partnered with Daiichi Sankyo and AstraZeneca to offer grants for research exploring ADCs against lung cancer

There are many ways to generate antibodies, but sometimes traditional methods don’t deliver what you need.

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

How increased biological understanding and advanced technology are generating new antibody-based modalities with exciting potential.

Endogena Therapeutics CEO Matthias Steger discusses fast track FDA approval for EA-2353, a new drug for the treatment of retinitis pigmentosa

What lies ahead for antibody discovery? We ask experts from RQ Bio.

Will next gen antibodies knock our socks off? Experts consider the future of antibody-based drug development

Carl June discusses his pathway into immunology, and the history and success of CAR-T therapy.